FSD Pharma (NASDAQ:HUGE) just reported results for the second quarter of 2024. FSD Pharma reported earnings per share of -8 cents. This was below the analyst estimate for EPS of -6 cents.
FSD Pharma Inc. (Nasdaq: HUGE) (CSE:HUGE) (FRA:0K9) (the “Company” or “FSD”) is pleased to announce the results of its annual general and special meeting of the shareholders held on May ...